156 related articles for article (PubMed ID: 33455296)
21. Effect of inorganic mesoporous carriers on 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol-loaded solid self-emulsifying drug delivery system: Physicochemical characterization and bioavailability in rats.
Kim DS; Yang ES; Yong CS; Youn YS; Oh KT; Li DX; Kim JO; Jin SG; Choi HG
Colloids Surf B Biointerfaces; 2017 Dec; 160():331-336. PubMed ID: 28957774
[TBL] [Abstract][Full Text] [Related]
22. Imine bond formation as a tool for incorporation of amikacin in self-emulsifying drug delivery systems (SEDDS).
Dizdarević A; Marić M; Shahzadi I; Ari Efiana N; Matuszczak B; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2021 May; 162():82-91. PubMed ID: 33737147
[TBL] [Abstract][Full Text] [Related]
23. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
Song WH; Yeom DW; Lee DH; Lee KM; Yoo HJ; Chae BR; Song SH; Choi YW
Arch Pharm Res; 2014 May; 37(5):626-35. PubMed ID: 23852645
[TBL] [Abstract][Full Text] [Related]
24. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.
Suchaoin W; Pereira de Sousa I; Netsomboon K; Lam HT; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2016 Aug; 510(1):255-62. PubMed ID: 27329673
[TBL] [Abstract][Full Text] [Related]
25. Mucolytic self-emulsifying drug delivery systems (SEDDS) containing a hydrophobic ion-pair of proteinase.
Lam HT; Le NN; Phan TNQ; Bernkop-Schnürch A
Eur J Pharm Sci; 2021 Jul; 162():105658. PubMed ID: 33271277
[TBL] [Abstract][Full Text] [Related]
26. Hydrophobic ion pairing-based self-emulsifying drug delivery systems: a new strategy for improving the therapeutic efficacy of water-soluble drugs.
Xin J; Qin M; Ye G; Gong H; Li M; Sui X; Liu B; Fu Q; He Z
Expert Opin Drug Deliv; 2023 Jan; 20(1):1-11. PubMed ID: 36408589
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterisation of self-emulsifying drug delivery system (SEDDS) for enhancing oral bioavailability of metformin hydrochloride using hydrophobic ion pairing complexation.
Rezvanjou SN; Niavand MR; Heydari Shayesteh O; Yeganeh EM; Ahmadi Moghadam D; Derakhshandeh K; Mahjub R
J Microencapsul; 2023 Jan; 40(1):53-66. PubMed ID: 36649282
[TBL] [Abstract][Full Text] [Related]
28. Oral delivery of calcitonin-ion pairs: In vivo proof of concept for a highly lipophilic counterion.
Wibel R; Jörgensen AM; Laffleur F; Spleis H; Claus V; Bernkop-Schnürch A
Int J Pharm; 2023 Jan; 631():122476. PubMed ID: 36528188
[TBL] [Abstract][Full Text] [Related]
29. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
Chudasama A; Patel V; Nivsarkar M; Vasu K; Shishoo C
Drug Deliv; 2015; 22(4):531-40. PubMed ID: 24601856
[TBL] [Abstract][Full Text] [Related]
30. Self-emulsifying drug delivery systems: In vivo evaluation of their potential for oral vaccination.
Lupo N; Tkadlečková VN; Jelkmann M; Laffleur F; Hetényi G; Kubová K; Bernkop-Schnürch A
Acta Biomater; 2019 Aug; 94():425-434. PubMed ID: 31228632
[TBL] [Abstract][Full Text] [Related]
31. Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: in vitro, in vivo and in situ intestinal permeability studies.
Shao B; Cui C; Ji H; Tang J; Wang Z; Liu H; Qin M; Li X; Wu L
Drug Deliv; 2015; 22(6):740-7. PubMed ID: 24670090
[TBL] [Abstract][Full Text] [Related]
32. Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity.
Valicherla GR; Dave KM; Syed AA; Riyazuddin M; Gupta AP; Singh A; Wahajuddin ; Mitra K; Datta D; Gayen JR
Sci Rep; 2016 May; 6():26895. PubMed ID: 27241877
[TBL] [Abstract][Full Text] [Related]
33. Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin.
Zupančič O; Partenhauser A; Lam HT; Rohrer J; Bernkop-Schnürch A
Eur J Pharm Sci; 2016 Jan; 81():129-36. PubMed ID: 26485536
[TBL] [Abstract][Full Text] [Related]
34. Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view.
Chatterjee B; Hamed Almurisi S; Ahmed Mahdi Dukhan A; Mandal UK; Sengupta P
Drug Deliv; 2016 Nov; 23(9):3639-3652. PubMed ID: 27685505
[TBL] [Abstract][Full Text] [Related]
35. Self-Emulsifying Drug Delivery System for Enhancing Bioavailability and Lymphatic Delivery of Tacrolimus.
Cho HY; Choi JH; Oh IJ; Lee YB
J Nanosci Nanotechnol; 2015 Feb; 15(2):1831-41. PubMed ID: 26353739
[TBL] [Abstract][Full Text] [Related]
36. Self-emulsifying drug delivery systems: Design of a novel vaginal delivery system for curcumin.
Köllner S; Nardin I; Markt R; Griesser J; Prüfert F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2017 Jun; 115():268-275. PubMed ID: 28323109
[TBL] [Abstract][Full Text] [Related]
37. Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis.
Chamieh J; Domènech Tarrat A; Doudou C; Jannin V; Demarne F; Cottet H
Int J Pharm; 2019 Mar; 559():228-234. PubMed ID: 30703502
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of self-emulsifying drug delivery systems for oral insulin delivery using an in vitro model simulating the intestinal proteolysis.
Liu J; Hirschberg C; Fanø M; Mu H; Müllertz A
Eur J Pharm Sci; 2020 Apr; 147():105272. PubMed ID: 32084584
[TBL] [Abstract][Full Text] [Related]
39. Hydrophobic ion-pairs and lipid-based nanocarrier systems: The perfect match for delivery of BCS class 3 drugs.
Phan TNQ; Shahzadi I; Bernkop-Schnürch A
J Control Release; 2019 Jun; 304():146-155. PubMed ID: 31075345
[TBL] [Abstract][Full Text] [Related]
40. Role of solid carriers in pharmaceutical performance of solid supersaturable SEDDS of celecoxib.
Chavan RB; Modi SR; Bansal AK
Int J Pharm; 2015 Nov; 495(1):374-384. PubMed ID: 26364711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
